Frequency of Sexual Dysfunction In Women With Rheumatic Diseases PDF Print E-mail
Sunday, 07 July 2013 20:08
Sexuality is part of human life and of quality of life, accounting for individual well-being. It relates not only to sexual intercourse itself, but also to a whole spectrum that ranges from self-image and self-valuing to relationship with the ‘Other’. Appropriate sexual activity comprises phases from sexual arousal to relaxation, with pleasure and satisfaction.

Sexual dysfunction is a change in a phase of the sexual activity that can culminate in frustration, pain, and a reduction in the number of sexual intercourses. Some studies have shown a prevalence of sexual dysfunction in the general female population of as much as 40%. Chronic diseases are known to influence the quality of sexual life, but their effect is little studied, and sexual dysfunction, little diagnosed. This is due to two reasons: patients do not report their sexual dysfunctions because of shame or frustration, and physicians rarely ask their patients about those dysfunctions.

When asked, health professionals allege to have little time for consultation, lack of privacy in their medical offices, and lack of ability to discuss the issue. In addition, patients tend to avoid speaking about that subject. Recently, the Association Nationale de Défense Contre l’Arthrite Rhumatoïde (French Association for Rheumatoid Arthritis) has sent, via e-mail, a questionnaire about sexuality to their members. Only 38% responded, and 70% reported a negative impact of the disease on their sexual life. Seventy-two per cent reported never having spoken with their physicians about sexuality.

Studies on the Brazilian population that could help to delineate the real impact of rheumatic diseases on sexual functioning still lack. Knowing the extension of the problem is necessary, so that therapeutic possibilities can be provided, because sexual dysfunction is one of the major determinants of reduced quality of life.

This study aimed at assessing the prevalence of sexual dysfunction in women followed up in the Rheumatology Outpatient Clinic of the Hospital Universitário de Brasília (HUB) and the Hospital das Clínicas of the Universidade de São Paulo (HC-FMUSP), who have the following rheumatic diseases: systemic lupus erythematosus (SLE); rheumatoid arthritis (RA); systemic sclerosis (SSc); antiphospholipid antibody syndrome (APLS); and fibromyalgia (FM).

To continue reading the full study, please download from the link provided below.

 
More articles :

» Scientists and Clinicians Address Diagnosis and Treatment for Autoimmune and Autoinflammatory Diseases

Autoimmune and autoinflammatory diseases are a major health issue. The National Institutes of Health reports that up to 23.5 million Americans are afflicted. The American Autoimmune Related Diseases Association reports the number is closer to 50...

» Vascular Complications of Systemic Sclerosis during Pregnancy

Eliza F. Chakravarty, MD MSSystemic sclerosis (SSc) is a chronic autoimmune disorder characterized by progressive fibrosis of the skin and visceral tissues as well as a non-inflammatory vasculopathy. Vascular disease in systemic sclerosis is a major...

» Could The Drug Gleevec Be The First Possible Treatment For Scleroderma?

Investigators have identified a drug that is currently approved to treat certain types of cancer, , that could provide the first treatment for . The news will be presented at the annual meeting of the on October 18 in Philadelphia. "There has never...

» Endothelin Antagonists Present Great Promise

One of the most intriguing developments in recent medical science is the discovery of the human chemical endothelin (ET). Since its detection in 1988, over 22,000 scholarly articles (about 3 per day) have been published on the subject, a new class...

» Scleroderma Research Foundation To Host Patient Webinar Series

The announced the first in a series of free informational Webinars for people living with and others directly or indirectly affected by the disease. The first Webinar will highlight new clinical trials and results from recent studies.The 2011/2012...

» Erectile Dysfunction is Frequent in Systemic Sclerosis and Associated with Severe Disease: A Study of the EULAR Scleroderma Trial and Research Group

Chingching Foocharoen, Alan Tyndall, Eric Hachulla, Edoardo Rosato, Yannick Allanore, Dominique Farge-Bancel, Paola Caramaschi, Paolo Airó, Starovojtova M Nikolaevna, José A Pereira da Silva, Bojana Stamenkovic, Gabriela Riemekasten, Simona...

Comments  

 
+1 #1 cindy haan 2013-07-09 14:10
Taking any antidepressants along with scleroderma and having Pulmonary hypertension that often occurs with it...makes the dysfunction much worse. Noticed it as soon as I took Zoloft and cymbalta.
Report to administrator